Paradigm Clinical Research Announces Expansion of Site Locations
Paradigm Clinical Research announces the opening of its clinical research site in Littleton, CO, the company’s fourth location. The new site location complements the company’s long-standing site in Wheat Ridge, CO.
This expansion is a continuation of Paradigm Clinical Research’s growth strategy, which focuses on creating purpose-built research sites to fulfill the industry’s demand for study participants and the need for diverse populations and investigators. As part of this strategy, the company has partnered with Andy Fine, MD, who will serve as a principal investigator (PI) in Littleton. Fine is a primary care physician at Colorado Primary Health Care, which is the leading primary care group in the area, serving a large and diverse patient base.
Reference
Paradigm Clinical Research Announces Expansion of Site Locations. (2023, April 18). Paradigm Research.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
